5-Lipoxygenase: A Promising Drug Target Against Inflammatory Diseases-Biochemical and Pharmacological Regulation

E-ISSN： 1873-5592|15|4|410-422

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.4, 2014-04, pp. : 410-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5-Lipoxygenase: Regulation and Pharmacology

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 2, 2004-04 ,pp. : 201-223

Bentham Science Publishers

Access to resources Recommend Favorite

pH-Dependent regulation of leukocyte 5-lipoxygenase activity in inflammatory exudates by albumin

By Benz M. Werz O. Jacob R. Steinhilber D.

Inflammation Research, Vol. 46, Iss. 9, 1997-09 ,pp. : 366-372

Springer Publishing Company

Access to resources Recommend Favorite

Chorismate Synthase: An Attractive Target For Drug Development Against Orphan Diseases

Current Drug Targets, Vol. 8, Iss. 3, 2007-03 ,pp. : 437-444

Bentham Science Publishers

Access to resources Recommend Favorite

Ascomycins: promising agents for the treatment of inflammatory skin diseases

By Paul C. Graeber M. Stuetz A.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 1, 2000-01 ,pp. : 69-77

Informa Healthcare

Access to resources Recommend Favorite

The Interleukin-17/Interleukin-22 Innate Axis in the Gut as a New Drug Target in Allergic-Inflammatory and Autoimmune Diseases. A Working Hypothesis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 14, Iss. 2, 2014-06 ,pp. : 145-151

Bentham Science Publishers

Access to resources Recommend Favorite